about
Cardiac aging and heart disease in humansMultiple genetic loci within 11p15 defined by Beckwith-Wiedemann syndrome rearrangement breakpoints and subchromosomal transferable fragmentsMeta-analysis of muscle transcriptome data using the MADMuscle database reveals biologically relevant gene patterns.Immune response and mitochondrial metabolism are commonly deregulated in DMD and aging skeletal muscle.Molecular signature of mineralocorticoid receptor signaling in cardiomyocytes: from cultured cells to mouse heartA long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation.Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21+ fibroblast progenitor cell transformation into adipocytes and vascular cells.Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification.Transcriptomal analysis of failing and nonfailing human hearts.Transcriptional orchestration of mitochondrial homeostasis in a cellular model of PGC-1-related coactivator-dependent thyroid tumor.Multiple tumor suppressor genes in multistep carcinogenesis.Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man.Identification of genomic differences among peripheral arterial beds in atherosclerotic and healthy arteries.Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumourComparative genomic hybridization analysis of hepatoblastomas: additional evidence for a genetic link with Wilms tumor and rhabdomyosarcomaComparative genomic hybridization analysis of Wilms tumors[Arterial heterogeneity]Gap-134, a Connexin43 activator, prevents age-related development of ventricular fibrosis in Scn5a+/- mice
P50
Q33639771-FAF3080F-C777-4E63-B11A-2F69F5345F59Q33681805-DAA3E3CD-E324-4569-A7A0-0776B87B02B1Q33821544-391DB4FC-D8DD-4FA1-B7CD-8EF3F419F275Q34077720-24F6C804-C5E3-47E6-A3C1-A5E7E9EB77DDQ34132351-86BE4A38-C811-43C6-9F01-8E88C6226CE2Q35134951-E5398F4F-D89B-41C6-8D14-E1A25DFEB6FDQ42378811-C4937027-D94B-4E90-BBE8-09CA58BE7943Q48159039-E05F0523-EAF7-48DD-84EA-5DD0C122125AQ52112465-B1AEC7B2-16F5-4D47-B555-26FC1141AF11Q52319527-73E93661-8DC6-42E6-A62E-32A7DC740D8CQ53487267-BEC44993-F3DA-446C-A87F-613DE32C6280Q54634849-435389CA-4DA5-4779-BEF8-C8CC7FEF880BQ55040072-C0E6A429-973B-4A81-8674-4C4D5301B0DAQ72703028-739B186D-B340-47A9-952A-FAEEC019519DQ73142906-9D9F5106-5F1A-4BA5-B9B5-6E039B0A4E09Q73668835-DE46183C-7D24-40A9-AA95-833E0FD6AC98Q85472162-C7E1E51E-19FB-43E5-9E99-B92DBF195F5BQ95943277-C850FEDA-1395-4467-9270-AB761CF8770B
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-4547-4448
@en
name
Marja Steenman
@ast
Marja Steenman
@en
Marja Steenman
@es
Marja Steenman
@nl
type
label
Marja Steenman
@ast
Marja Steenman
@en
Marja Steenman
@es
Marja Steenman
@nl
prefLabel
Marja Steenman
@ast
Marja Steenman
@en
Marja Steenman
@es
Marja Steenman
@nl
P106
P31
P496
0000-0003-4547-4448